Features | Healtcare News | BioTuesdays by Kilmer Lucas IR

Feature

NeuroOne developing electrode technology to treat neurological conditions

NeuroOne (OTCQB:NMTC) is developing high-definition, minimally invasive thin-film electrodes for the diagnosis and treatment of various neurological conditions, including epilepsy, Parkinson’s disease (PD) and chronic...

July 14, 2020

Feature

Loki Therapeutics harnessing antigens from traditional childhood vaccinations for immunotherapy

Unlike the traditional approach to immunotherapy, which teaches the body to recognize tumor antigens as something foreign to be attacked, closely-held Loki Therapeutics’ AWAKE technology makes cancer appear as something...

July 7, 2020

Feature

Passage Bio developing transformative therapies for rare, life-threatening genetic disorders

Passage Bio (NASDAQ:PASG) is focused on developing transformative, differentiated therapies for rare, life-threatening monogenic CNS disorders, with the goal of mitigating development risk. “We believe that our rigorous...

June 30, 2020

Feature

CohBar developing therapeutics from mitochondrial DNA

CohBar (NASDAQ:CWBR) is transforming peptides encoded and expressed by mitochondria, some of which control a wide range of systems in the body, into novel therapeutics. “Harnessing the power of mitochondria biology to...

June 23, 2020

Feature

Cidara platforms targeting prophylactics and treatments for fungal, viral infections

Cidara Therapeutics (NASDAQ:CDTX) is developing what may be the first antifungal to be approved in 15 years for both the treatment and prevention of invasive fungal disease.

June 16, 2020

Feature

Seven questions for Ian Koenig of Investis Digital about expediting patient recruitment for clinical trials

In his role as SVP of life sciences, Ian Koenig brings broad experience to Investis Digital in communications strategy, digital marketing, investor relations and business development on behalf of biopharma globally. Mr...

June 9, 2020

Feature

Chris Kaplan of ITG talks up market-making in capital markets

As a VP of Independent Trading Group (ITG), an issuer designated market making firm, Chris Kaplan brings a more institutional approach to provide liquidity for clients with stocks that are thinly traded. ITG, which is...

June 2, 2020

Feature

SetPoint Medical developing bioelectric treatment for RA, chronic autoimmune diseases

Closely-held SetPoint Medical is pioneering electric stimulation of the vagus nerve in the neck as a treatment for rheumatoid arthritis (RA) and other chronic autoimmune diseases, such as Crohn’s disease, ulcerative...

May 26, 2020

Feature

Spring Bank Pharma may expand R&D with potential COVID-19 agents

After abruptly ending its hepatitis B virus program in January, Spring Bank Pharmaceuticals (NASDAQ:SBPH) is in the early stages of examining whether its family of RIG-I agonists have the potential to attack SARS-CoV-2...

May 19, 2020

Feature

COVID-19 presents opportunities and challenges for Field Trip Psychedelics

Despite delays in dosing of patients at its Toronto clinic and building its network of clinics in the U.S. because of COVID-19, closely-held Field Trip Psychedelics is finding opportunities to expand its psychedelic...

May 12, 2020

Feature

Eyenovia micro-array print therapeutics targeting various ophthalmic indications

Eyenovia (NASDAQ:EYEN) is using its unique microdose drug delivery technology, Optejet, to build a late-stage pipeline of ophthalmic therapeutics. “We have three late-stage programs for three major indications that we...

May 5, 2020

Feature

Daxor targeting blood volume analysis to reduce mortality and ventilator use in ICU

Daxor’s (NYSE American:DXR) BVA-100 blood volume measurement device is helping to open a new front in the battle against COVID-19. “Optimal volume management and knowledge of capillary status is key to survivability...

April 28, 2020

Feature

Clarigent Health using AI, machine learning for early detection of potential mental health crises

Closely-held Clarigent is developing a tool to support the early detection of mental health issues, with a goal of preventing suicide in at-risk children and adolescents. “The suicide rate, especially among school-aged...

April 21, 2020

Feature

NanoViricides targeting multiple types of viral infection with nanomedicine platform

Using its nanomedicine platform and the capabilities of its cGMP manufacturing facility, NanoViricides (NYSE American: NNVC) is developing therapeutics for a variety of viral infections, including herpes simplex viruses...

April 14, 2020

Feature

Dr. Doug Manion of Kleo Pharmaceuticals talks up new approach to treating multiple myeloma

As chairman and CEO of Kleo Pharmaceuticals, a private immuno-oncology company developing next-generation bispecific compounds designed to enhance the activity of biologics, Dr. Doug Manion has a distinguished pedigree...

April 7, 2020

Feature

Amidst a global pandemic, two biotech companies offer innovative solutions

Since COVID-19 was first identified in China late last year, researchers have been working tirelessly to develop diagnostics, therapeutics and vaccines in an effort to prevent the spread of the SARS-CoV-2 virus. Many...

March 31, 2020

Feature

Bee Vectoring bringing nature’s solution to healthy crops

Using the natural pollination process of commercially-reared bees and biological products and controls, Bee Vectoring Technology International (TSXV, CVE:BEE; OTCQB:BEVVF) has developed a pest and disease solution for...

March 24, 2020

Feature

Obalon developing retail strategy for its weight loss solution: a swallowable, gas-filled intragastric balloon

Obalon Therapeutics (NASDAQ:OBLN) is pivoting its business model to a retail strategy of company-managed clinics to deliver its Obalon Balloon System, a weight loss solution that is the first and only swallowable, gas...

March 17, 2020

Feature

Diabeloop bringing innovation to Type 1 diabetes patients

Closely-held Diabeloop of Grenoble, France has developed an external Type 1 diabetes management system, known as DBLG1, that connects three components: a continuous glucose monitor, a patch-like insulin pump and an...

March 10, 2020

Feature

Anixa Biosciences harnessing interactions between tumors and the immune system

Anixa Biosciences (NASDAQ:ANIX) is taking multiple approaches to fighting cancer, developing both a diagnostic and therapeutics, such as a cancer immunotherapy and vaccine, to overcome immuno-suppression. Anixa...

March 3, 2020

Feature

Ocugen developing therapies for rare and underserved eye diseases

Ocugen (NASDAQ:OCGN) is taking a multi-pronged approach to ophthalmology with a diversified pipeline that includes a breakthrough modifier gene therapy platform, novel biologics and small molecules, targeting a broad...

February 25, 2020

Feature

Genocea Biosciences: for the next generation of immunotherapies, targets matter

Using its unique ATLAS proprietary technology platform, Genocea Biosciences (NASDAQ:GNCA) is developing cancer immunotherapies that direct the body’s own tumor-fighting T-cells to the most therapeutically relevant...

February 18, 2020

NeuroOne developing electrode technology to treat neurological conditions

Loki Therapeutics harnessing antigens from traditional childhood vaccinations for immunotherapy

Passage Bio developing transformative therapies for rare, life-threatening genetic disorders

CohBar developing therapeutics from mitochondrial DNA

Cidara platforms targeting prophylactics and treatments for fungal, viral infections

Seven questions for Ian Koenig of Investis Digital about expediting patient recruitment for clinical trials

Chris Kaplan of ITG talks up market-making in capital markets

SetPoint Medical developing bioelectric treatment for RA, chronic autoimmune diseases

Spring Bank Pharma may expand R&D with potential COVID-19 agents

COVID-19 presents opportunities and challenges for Field Trip Psychedelics

Eyenovia micro-array print therapeutics targeting various ophthalmic indications

Daxor targeting blood volume analysis to reduce mortality and ventilator use in ICU

Clarigent Health using AI, machine learning for early detection of potential mental health crises

NanoViricides targeting multiple types of viral infection with nanomedicine platform

Dr. Doug Manion of Kleo Pharmaceuticals talks up new approach to treating multiple myeloma

Amidst a global pandemic, two biotech companies offer innovative solutions

Bee Vectoring bringing nature’s solution to healthy crops

Obalon developing retail strategy for its weight loss solution: a swallowable, gas-filled intragastric balloon

Diabeloop bringing innovation to Type 1 diabetes patients

Anixa Biosciences harnessing interactions between tumors and the immune system

Ocugen developing therapies for rare and underserved eye diseases

Genocea Biosciences: for the next generation of immunotherapies, targets matter

General

More